ClinicalTrials.govpublic full text
A Safety and Tolerability Study of an Investigational Drug, ALN-TTRSC02, in Healthy Subjects
transthyretin-mediated amyloidosis (attr amyloidosis), ttr-mediated amyloidosis, amyloidosis, hereditary, amyloid neuropathies, familial, familial amyloid polyneuropathies, amyloid neuropathies, amyloidosis, hereditary, transthyretin-related, familial amyloidosis, rnai therapeutic, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 802278
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.